palladium 103
Showing 1 - 25 of 138
Early Stage Breast Cancer Trial in Kelowna (Stranded palladium seed interstitial implant, 3 dimensional breast ultrasound,
Active, not recruiting
- Early Stage Breast Cancer
- Stranded palladium seed interstitial implant
- +2 more
-
Kelowna, British Columbia, CanadaBCCA Center for the Southern Interior
Mar 3, 2022
Sarcoma Trial in Chicago, Philadelphia (CivaSheet)
Recruiting
- Sarcoma
- CivaSheet
-
Chicago, Illinois
- +1 more
Mar 1, 2022
Prostate Cancer Trial in Chicago, New York, Norfolk (Linear LDR Source)
Active, not recruiting
- Prostate Cancer
- Linear LDR Source
-
Chicago, Illinois
- +2 more
Mar 1, 2022
Breast Tumors Trial in Toronto (Permanent breast seeds implant)
Completed
- Breast Neoplasms
- Permanent breast seeds implant
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
Oct 22, 2021
Abdominal Malignancy, Pelvic Malignancy Trial in New York (device, radiation, procedure)
Active, not recruiting
- Abdominal Malignancy
- Pelvic Malignancy
- CivaSheet
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 19, 2021
Pancreatic Cancer Trial in United States (Directional Brachytherapy Source Implant)
Recruiting
- Pancreatic Cancer
- Directional Brachytherapy Source Implant
-
Chicago, Illinois
- +4 more
Mar 1, 2022
Lung Cancer, Lung Cancer Stage I, Lung Cancer Stage II Trial in Mission Viejo, New York (CivaSheet)
Recruiting
- Lung Cancer
- +2 more
- CivaSheet
-
Mission Viejo, California
- +2 more
May 23, 2022
Pancreas Cancer, Cancer Trial in Greenville (CivaSheet)
Active, not recruiting
- Pancreas Cancer
- Cancer
- CivaSheet
-
Greenville, North CarolinaEast Carolina University, Brody School of Medicine
Mar 1, 2022
Irritable Bowel Syndrome With Diarrhea Trial (CIN-103, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome With Diarrhea
- CIN-103
- Placebo
- (no location specified)
Nov 22, 2023
Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Pembrolizumab, IO102-103)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
-
Baltimore, MarylandJohns Hopkins University
Aug 2, 2023
Wiskott-Aldrich Syndrome Trial in Atlanta, Milan (OTL-103)
Active, not recruiting
- Wiskott-Aldrich Syndrome
- OTL-103
-
Atlanta, Georgia
- +1 more
Sep 27, 2022
Irritability Associated With Autism Spectrum Disorder Trial in United States (Pimavanserin)
Recruiting
- Irritability Associated With Autism Spectrum Disorder
-
Phoenix, Arizona
- +3 more
Jan 10, 2023
Solid Tumors Trial in Kashiwa, Nishinomiya, Chuo-ku (TAK-103)
Recruiting
- Solid Tumors
- TAK-103
-
Kashiwa, Chiba, Japan
- +2 more
Mar 10, 2022
Prostate Cancer Trial in Leeds (Radical Prostatectomy, Brachytherapy)
Terminated
- Prostate Cancer
- Radical Prostatectomy
- Brachytherapy
-
Leeds, England, United KingdomLeeds Cancer Centre at St. James's University Hospital
Dec 16, 2021
Influenza Trial in Toronto, Mirabel, Pointe-Claire (H1 influenza antigen)
Completed
- Influenza
- H1 influenza antigen
-
Toronto, Ontario, Canada
- +2 more
Nov 3, 2023
Metastatic Pancreatic Cancer Trial in Spain (OMO-103, Nab-Paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Cancer
- OMO-103
- +2 more
-
LĀ“Hospitalet de Llobregat, Barcelona, Spain
- +3 more
Sep 22, 2023
Prostate Cancer Trial in Canada, United States (Brachytherapy (100/110), Brachytherapy (125/145), External Beam Radiation
Unknown status
- Prostate Cancer
- Brachytherapy (100/110)
- +2 more
-
Phoenix, Arizona
- +169 more
Nov 2, 2021
Kidney Diseases, Kidney Injury, Kidney Failure Trial in Suzhou, Xuzhou (MB-102 DMID, MB-102 OMID, MediBeacon Transdermal
Recruiting
- Kidney Diseases
- +2 more
- MB-102 DMID
- +2 more
-
Suzhou, Jiangsu, China
- +1 more
Jul 11, 2023
Advanced Solid Tumors, NSCLC, Triple-negative Breast Cancer Trial in Barcelona, Madrid (OMO-103)
Active, not recruiting
- Advanced Solid Tumors
- +3 more
- OMO-103
-
Barcelona, Spain
- +2 more
Sep 27, 2022
Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)
Not yet recruiting
- Leukemia, Lymphoblastic
- Leukemia
-
Houston, TexasMD Anderson Cancer Center
Jul 19, 2022
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
- CB-103
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 14, 2023
Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's
Active, not recruiting
- Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
- CST-103, CST-107, matching placebo
-
Sydney, New South Wales, Australia
- +6 more
Jun 1, 2022